Showing results (541-550 of 847) with videos related to

Sort By:
Pageof 85
JNCI Cancer Spectrum|September 19, 2025
Therapy-Related-Myeloid-Neoplasm-Risk Score: a convenient score for therapy-related myeloid neoplasms risk assessment in adult cancer patientsAbhay Singh, Megan M Herr, Rahul Mishra, et al.
JNCI Cancer Spectrum|September 19, 2025
Pre-diagnostic circulating bile acid concentrations and liver cancer risk: a nested case-control analysis of 12 cohortsCody Z Watling, Jessica L Petrick, Barry I Graubard, et al.
JNCI Cancer Spectrum|September 10, 2025
Physical activity and mobility disability in older adult cancer survivorsJustin C Brown, Shengping Yang
JNCI Cancer Spectrum|August 12, 2025
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world dataAdam M Brufsky, Kent F Hoskins, Henry J Conter, et al.
JNCI Cancer Spectrum|April 30, 2021
Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal CancerMark A Jenkins, Daniel D Buchanan, John Lai, et al.
JNCI Cancer Spectrum|July 16, 2025
The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trialsElaine Chang, Haley Gittleman, Chi Song, et al.
JNCI Cancer Spectrum|December 17, 2025
Disparities in cardiometabolic and cardiovascular risk after breast cancer: the pathways heart studyAndrea E Diaz, Marilyn L Kwan, Cecile A Laurent, et al.
JNCI Cancer Spectrum|December 24, 2025
How to improve the cancer continuum for transgender and gender-diverse patientsTheodore E Schall, Nfn Scout, Adrian Shanker, et al.
JNCI Cancer Spectrum|December 15, 2025
Curability of metastatic cancer: a survey of medical oncologistsShalini Subramaniam, Kim Tam Bui, Martin R Stockler, et al.
JNCI Cancer Spectrum|December 19, 2024
The need for a cancer exposome atlas: a scoping reviewAnna S Young, Catherine E Mullins, Neha Sehgal, et al.
Pageof 85